Investment
Features
FeesSafety
Academy
More
Pluang+

US importer sues Trump administration over costly 50% tariffs on Canadian cheese and goods

Market News
20 Oct 2026
New York Post
View Source
Bearish
US importer sues Trump administration over costly 50% tariffs on Canadian cheese and goods

The Liberty Justice Center sued the Trump administration on behalf of Gellert Global Group, a New Jersey importer, challenging the 50% tariffs imposed on Canadian goods including cheese, alcohol, and cement. These tariffs, enacted amid a trade dispute, are estimated to cost Gellert $40 million annually on cheese imports alone. The lawsuit argues that President Trump exceeded his authority by imposing these tariffs without Congressional approval, targeting Section 338 of the Tariff Act of 1930, which had never been used before. This legal challenge follows previous successful litigation that overturned other Trump tariffs, highlighting ongoing tensions and uncertainties in US-Canada trade relations.

The Trump administration's tariffs on Canadian products provide context for consumer staples market activity. For readers following consumer staples, here is Pluang's market snapshot as of Oct 21, 2026 04:31 WIB: Of 63 priced US consumer staples stocks, 41 rose and 22 fell. Notable movers include ADM at USD 80.54 with a -2.51% change, Tyson Foods at USD 55.29 with +2.39%, and Clorox at USD 87.38 with +2.13%.

More News

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...

Company Fundamentals
Neutral
28 minutes ago
Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...

Company Fundamentals
Bullish
30 minutes ago
Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
1 hour ago
Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James raises Rapport Therapeutics price target to $86 after positive Phase 2 trial for bipolar mania drug.

Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...

Analyst Insights
Bullish
2 hours ago
Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express Q3 revenue falls 8.7%, misses estimates but returns to profit

Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...

Company Fundamentals
Bearish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App